<?xml version="1.0" encoding="UTF-8"?>
<p>The new compound 
 <bold>9</bold> was evaluated for its antibacterial activities against 
 <italic>Mycobacterium tuberculosis</italic>, 
 <italic>Staphylococcus aureus</italic> (ATCC25923), 
 <italic>S. aureus</italic> (ATCC700699), 
 <italic>Enterococcus faecalis</italic> (ATCC29212), 
 <italic>E. faecalis</italic> (ATCC51299), 
 <italic>E. faecium</italic> (ATCC35667), 
 <italic>E. faecium</italic> (ATCC700221) and 
 <italic>Acinetobacter baumannii</italic> (ATCCBAA1605). It showed very weak inhibitory effect against 
 <italic>M. tuberculosis</italic> (MIC &gt; 50 ÂµM) [
 <xref rid="B12-ijms-22-00959" ref-type="bibr">12</xref>].
</p>
